Annual report pursuant to Section 13 and 15(d)

Quarterly Financial Data (Unaudited) (Tables)

v3.20.1
Quarterly Financial Data (Unaudited) (Tables)
12 Months Ended
Dec. 31, 2019
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Quarterly Financial Information

The operating results for any quarter are not necessarily indicative of results for any future period.

 

    Quarters Ended  
    December 31,
2019
    September 30,
2019
    June 30,
2019
    March 31,
2019
 
Foundation revenues   $ -     $ -     $ -     $ -  
Royalties     -       -       -       -  
Research and development     9,605,000       10,917,000       16,307,000       11,737,000  
General and administrative     4,734,000       4,700,000       5,612,000       5,659,000  
Loss from operations     (16,411,000 )     (17,649,000 )     (23,976,000 )     (19,054,000 )
Net loss     (16,431,000 )     (17,372,000 )     (23,924,000 )     (18,555,000 )
Basic and diluted loss per common share     (0.30 )     (0.35 )     (0.49 )     (0.39 )
Weighted average number of common shares outstanding – basic and diluted     54,718,776       49,721,753       48,961,988       47,948,421  

 

    Quarters Ended    
      December 31,
2018
      September 30,
2018
      June 30,
2018
      March 31,
2018
 
Foundation revenues   $ 369,000     $ 1,687,000     $ 259,000     $ 481,000  
Royalties     113,000       22,000       17,000       50,000  
Research and development     9,470,000       13,150,000       7,916,000       8,162,000  
General and administrative     7,631,000       4,970,000       4,627,000       2,878,000  
Loss from operations     (18,010,000 )     (16,916,000 )     (12,557,000 )     (10,683,000 )
Net loss     (17,479,000 )     (16,419,000 )     (12,243,000 )     (10,530,000 )
Basic and diluted loss per common share     (0.36 )     (0.34 )     (0.26 )     (0.22 )
Weighted average number of common shares outstanding – basic and diluted     47,944,486       47,794,394       47,303,518       47,060,523